Skip to main content
Top
Published in: European Journal of Trauma and Emergency Surgery 2/2022

01-04-2022 | Biomarkers | Original Article

Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome

Authors: Olufemi Emmanuel Idowu, Stevens Olaide Oyeleke, Julius Mautin Vitowanu

Published in: European Journal of Trauma and Emergency Surgery | Issue 2/2022

Login to get access

Abstract

Introduction

Chronic subdural haematoma (CSH) has multifactorial mechanisms involved in its development and progression. Identifying readily available inflammatory and coagulation indices that can predict the prognosis of CSH will help in clinical care, prognosis, generating objective criteria for assessing efficacy of treatment strategies and comparisons of treatment efficacy between clinical studies. We conducted a study in which we evaluated the impact value of neutrophil to lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), inflammatory biomarkers (erythrocyte sedimentation rate and C-reactive protein), activated partial thromboplastin time (APTT), prothrombin time (PT) and international normalized ratio (INR) at presentation on CSH severity and outcome using Glasgow outcome scale (GOS), Markwalder grading scale (MGS) and Lagos brain disability examination scale (LABDES).

Methods

We prospectively studied patients in a single healthcare system with clinical and radiological features of chronic subdural haematoma. Only patients who were managed surgically were recruited. The primary outcome was predictors of severe form CSH (using admission Glasgow coma scale score, MGS grade, inflammatory cells and biomarkers, APTT, PT, and INR) and outcome (using GOS, MGS and LABDES grades 3 months) with secondary outcome being mortality rate, 3 months following surgery. Good outcome was defined as GOS score > 3, LABDES score ≥ 40 at three months and MGS score < 2. Differences in categorical and continuous variables between groups were compared using Fisher’s exact test or Chi-square test (χ2) analysis, one-way ANOVA or Kruskal–Wallis test (in case of non-normal distribution).

Results

We included 61 patients with a male-to-female ratio of 2.6:1 and mean age of 57.5 ± 13.3 years (median 58 years; 27–83 years). The pre-op MGS grade was significantly associated with the LABDES (p = 0.034), GOS (p = 0.011) and post-op MGS (p = 0.007) grade. All the patients that died had elevated APTT and PT with low PLR. A low admission PLR was significantly associated with a poor outcome using the GOS (p = 0.001), MGS (p = 0.011) and LABDES grade (p = 0.006) (Table 3). A high APTT was also significantly associated with a worse outcome using GOS (p = 0.007), MGS (p = 0.007) and LABDES grade (p = 0.003). There were three (4.9%) deaths with post-mortem diagnosis of pulmonary embolism, chronic renal failure and irreversible craniocaudal herniation syndrome. All the patients that died had elevated APTT and PT with low PLR.

Conclusion

Patients’ admission APTT, PT, INR and PLR are good predictors of outcome using the GOS. A high admission INR is also associated with a worse outcome using MGS and LABDES grade.
Literature
1.
go back to reference Stoodley M, Weir B. Contents of chronic subdural hematoma. NeurosurgClin N Am. 2000;11(3):425–34.CrossRef Stoodley M, Weir B. Contents of chronic subdural hematoma. NeurosurgClin N Am. 2000;11(3):425–34.CrossRef
3.
go back to reference Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27:894–908.PubMedCrossRef Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27:894–908.PubMedCrossRef
4.
go back to reference Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Dávalos A. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005;36:86–91.PubMedCrossRef Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Dávalos A. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005;36:86–91.PubMedCrossRef
5.
go back to reference Liu X, Shen Y, Wang H, Ge Q, Fei A, Pan S. Prognostic significance of neutrophil-to lymphocyte ratio in patients with sepsis: a prospective observational study. Mediators Inflamm. 2016;2016:8191254.PubMedPubMedCentral Liu X, Shen Y, Wang H, Ge Q, Fei A, Pan S. Prognostic significance of neutrophil-to lymphocyte ratio in patients with sepsis: a prospective observational study. Mediators Inflamm. 2016;2016:8191254.PubMedPubMedCentral
6.
go back to reference Hwang SY, Shin TG, Jo IJ, Jeon K, Suh GY, Lee TR, Yoon H, Cha WC, Sim MS. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am J Emerg Med. 2017;35(2):234–9.CrossRefPubMed Hwang SY, Shin TG, Jo IJ, Jeon K, Suh GY, Lee TR, Yoon H, Cha WC, Sim MS. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am J Emerg Med. 2017;35(2):234–9.CrossRefPubMed
7.
go back to reference Riché F, Gayat E, Barthélémy R, Le Dorze M, Matéo J, Payen D. Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit Care. 2015;19(1):439.PubMedPubMedCentralCrossRef Riché F, Gayat E, Barthélémy R, Le Dorze M, Matéo J, Payen D. Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit Care. 2015;19(1):439.PubMedPubMedCentralCrossRef
8.
go back to reference Sato S, Suzuki J. Ultrastructural observations of the capsule of chronic subdural haematoma in various clinical stages. J Neurosurg. 1975;43:569–78.PubMedCrossRef Sato S, Suzuki J. Ultrastructural observations of the capsule of chronic subdural haematoma in various clinical stages. J Neurosurg. 1975;43:569–78.PubMedCrossRef
9.
go back to reference Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T. Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. Cancer Med. 2014;3:406–15.PubMedPubMedCentralCrossRef Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T. Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. Cancer Med. 2014;3:406–15.PubMedPubMedCentralCrossRef
10.
go back to reference Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014;234:206–13.PubMedCrossRef Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014;234:206–13.PubMedCrossRef
11.
go back to reference Kundi H, Balun A, Cicekcioglu H, Cetin M, Kiziltunc E, Cetin ZG, Mansuroglu C, Ornek E. The relation between platelet-to-lymphocyte ratio and Pulmonary Embolism Severity Index in acute pulmonary embolism. Heart Lung. 2015;44:340–3.PubMedCrossRef Kundi H, Balun A, Cicekcioglu H, Cetin M, Kiziltunc E, Cetin ZG, Mansuroglu C, Ornek E. The relation between platelet-to-lymphocyte ratio and Pulmonary Embolism Severity Index in acute pulmonary embolism. Heart Lung. 2015;44:340–3.PubMedCrossRef
12.
go back to reference Ozcan Cetin EH, Cetin MS, Aras D, Topaloglu S, Temizhan A, Kisacik HL, Aydogdu S. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology. 2016;67:336–45.PubMedCrossRef Ozcan Cetin EH, Cetin MS, Aras D, Topaloglu S, Temizhan A, Kisacik HL, Aydogdu S. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology. 2016;67:336–45.PubMedCrossRef
13.
go back to reference Yang W, Liu Y. Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients. Thromb Res. 2015;136:212–5.PubMedCrossRef Yang W, Liu Y. Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients. Thromb Res. 2015;136:212–5.PubMedCrossRef
14.
go back to reference Tokgoz S, Kayrak M, Akpinar Z, Seyithanoglu A, Guney F, Yuruten B. Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis. 2013;22:1169–74.PubMedCrossRef Tokgoz S, Kayrak M, Akpinar Z, Seyithanoglu A, Guney F, Yuruten B. Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis. 2013;22:1169–74.PubMedCrossRef
15.
go back to reference Wang F, Hu S, Ding Y, et al. Neutrophil-to-lymphocyte ratio and 30-day mortality in patients with acute intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2016;25:182–7.PubMedCrossRef Wang F, Hu S, Ding Y, et al. Neutrophil-to-lymphocyte ratio and 30-day mortality in patients with acute intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2016;25:182–7.PubMedCrossRef
16.
go back to reference Idowu OE, Oshinaike O, Ogun SA, Arabambi B, Orungbeja TO, Malomo OO, Aisudo CK, Oyeleye OO. Predicting outcome in traumatic brain injury using a new outcome assessment scale—The Lagos Brain Disability Examination Scale (LABDES). Trauma. 2019;22(2):148–54.CrossRef Idowu OE, Oshinaike O, Ogun SA, Arabambi B, Orungbeja TO, Malomo OO, Aisudo CK, Oyeleye OO. Predicting outcome in traumatic brain injury using a new outcome assessment scale—The Lagos Brain Disability Examination Scale (LABDES). Trauma. 2019;22(2):148–54.CrossRef
17.
go back to reference Chen JCT, Levy ML. Causes, epidemiology, and risk factors of chronic subdural hematoma. Neurosurg Clin N Am. 2000;11(3):399–406.PubMedCrossRef Chen JCT, Levy ML. Causes, epidemiology, and risk factors of chronic subdural hematoma. Neurosurg Clin N Am. 2000;11(3):399–406.PubMedCrossRef
18.
go back to reference Sajanti J, Majamaa K. High concentrations of procollagen propeptides in chronic subdural haematoma and effusion. J Neurol Neurosurg Psychiatry. 2003;74:522.PubMedPubMedCentralCrossRef Sajanti J, Majamaa K. High concentrations of procollagen propeptides in chronic subdural haematoma and effusion. J Neurol Neurosurg Psychiatry. 2003;74:522.PubMedPubMedCentralCrossRef
19.
go back to reference Ito H, Yamamoto S, Saito K, Ikeda K, Hisada K. Quantitative estimation of haemorrhage in chronic subdural haematoma using the 51Cr erythrocyte labelling method. J Neurosurg. 1987;66:862–4.PubMedCrossRef Ito H, Yamamoto S, Saito K, Ikeda K, Hisada K. Quantitative estimation of haemorrhage in chronic subdural haematoma using the 51Cr erythrocyte labelling method. J Neurosurg. 1987;66:862–4.PubMedCrossRef
20.
21.
go back to reference Sambasivan M. An overview of chronic subdural hematoma: experience with 2300 cases. Surg Neurol. 1997;47:418–22.PubMedCrossRef Sambasivan M. An overview of chronic subdural hematoma: experience with 2300 cases. Surg Neurol. 1997;47:418–22.PubMedCrossRef
22.
go back to reference Hohenstein A, Erber R, Schilling L, Weigel R. Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma. J Neurotrauma. 2005;22(5):518–28.PubMedCrossRef Hohenstein A, Erber R, Schilling L, Weigel R. Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma. J Neurotrauma. 2005;22(5):518–28.PubMedCrossRef
23.
go back to reference Hara M, Tamaki M, Aoyagi M, et al. Possible role of cyclooxygenase-2 in developing chronic subdural haematoma. J Med Dent Sci. 2009;56:101–6.PubMed Hara M, Tamaki M, Aoyagi M, et al. Possible role of cyclooxygenase-2 in developing chronic subdural haematoma. J Med Dent Sci. 2009;56:101–6.PubMed
24.
go back to reference Shono T, Inamura T, Morioka T. Vascular endothelial growth factor in chronic subdural haematomas. J Clin Neurosci. 2001;8(5):411–5.PubMedCrossRef Shono T, Inamura T, Morioka T. Vascular endothelial growth factor in chronic subdural haematomas. J Clin Neurosci. 2001;8(5):411–5.PubMedCrossRef
25.
go back to reference Nanko N, Tanikawa M, Mase M, Fujita M, Tateyama H, Miyati T, Yamada K. Involvement of hypoxia-induciblefactor-1a and VEGF in the mechanism and development of chronic subdural haematoma. Neurol Med Chir (Tokyo). 2009;49(9):379–85.CrossRef Nanko N, Tanikawa M, Mase M, Fujita M, Tateyama H, Miyati T, Yamada K. Involvement of hypoxia-induciblefactor-1a and VEGF in the mechanism and development of chronic subdural haematoma. Neurol Med Chir (Tokyo). 2009;49(9):379–85.CrossRef
26.
go back to reference Kalamatianos T, Stavrinou LC, Koutsarnakis C, Psachoulia C, Sakas DE, Stranjalis G. PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development. J Neurosurg. 2013;118(2):353–7.PubMedCrossRef Kalamatianos T, Stavrinou LC, Koutsarnakis C, Psachoulia C, Sakas DE, Stranjalis G. PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development. J Neurosurg. 2013;118(2):353–7.PubMedCrossRef
27.
go back to reference Hua C, Zhao G, Feng Y, Yuan H, Song H, Bie L, Ogawa A. Role of matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor in the development of chronic subdural hematoma. J Neurotrauma. 2016;33(1):65–70.PubMedPubMedCentralCrossRef Hua C, Zhao G, Feng Y, Yuan H, Song H, Bie L, Ogawa A. Role of matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor in the development of chronic subdural hematoma. J Neurotrauma. 2016;33(1):65–70.PubMedPubMedCentralCrossRef
28.
go back to reference Vaquero J, Zurita M, Cincu R. Vascular endothelial growth-permeability factor in granulation tissue of chronic subdural haematomas. Acta Neurochir (Wien). 2002;144(4):343–6.CrossRef Vaquero J, Zurita M, Cincu R. Vascular endothelial growth-permeability factor in granulation tissue of chronic subdural haematomas. Acta Neurochir (Wien). 2002;144(4):343–6.CrossRef
29.
go back to reference Jung S, Moon KS, Jung TY, Kim IY, Lee YH, Rhu HH, Sun HS, Jeong YI, Kim K, Kang S. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage. J Neurooncol. 2006;76(3):257–63.PubMedCrossRef Jung S, Moon KS, Jung TY, Kim IY, Lee YH, Rhu HH, Sun HS, Jeong YI, Kim K, Kang S. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage. J Neurooncol. 2006;76(3):257–63.PubMedCrossRef
30.
go back to reference Hong HJ, Kim YJ, Yi HJ, Yi H, Ko Y, Oh S, Kim J. Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol. 2009;71(2):161–5.PubMedCrossRef Hong HJ, Kim YJ, Yi HJ, Yi H, Ko Y, Oh S, Kim J. Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol. 2009;71(2):161–5.PubMedCrossRef
31.
go back to reference Stanisic M, Lyngstadaas SP, Pripp AH, Aasen AO, Lindegaard KF, Ivanovic J, Ilstad E, Konglund A, Sandell T, Ellingsen O, Saehle T. Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural haematoma: a prospective study. Acta Neurochir. 2012;154:113–20.PubMedCrossRef Stanisic M, Lyngstadaas SP, Pripp AH, Aasen AO, Lindegaard KF, Ivanovic J, Ilstad E, Konglund A, Sandell T, Ellingsen O, Saehle T. Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural haematoma: a prospective study. Acta Neurochir. 2012;154:113–20.PubMedCrossRef
32.
go back to reference Kitazono M, Yokota H, Satoh H, Onda H, Matsumoto G, Fuse A, Teramoto A. Measurement of inflammatory cytokines and thrombomodulin in chronic subdural hematoma. Neurol Med Chir (Tokyo). 2012;52(11):810–5.CrossRef Kitazono M, Yokota H, Satoh H, Onda H, Matsumoto G, Fuse A, Teramoto A. Measurement of inflammatory cytokines and thrombomodulin in chronic subdural hematoma. Neurol Med Chir (Tokyo). 2012;52(11):810–5.CrossRef
33.
go back to reference Wada T, Kuroda K, Yoshida Y, Ogasawara K, Ogawa A, Endo S. Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma. Neurosurg Rev. 2006;29(3):242–5.PubMedCrossRef Wada T, Kuroda K, Yoshida Y, Ogasawara K, Ogawa A, Endo S. Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma. Neurosurg Rev. 2006;29(3):242–5.PubMedCrossRef
34.
go back to reference Kitazono M, Yokota H, Satoh H, Onda H, Matsumoto G, Fuse A, Akira T. Measurement of inflammatory cytokines and thrombomodulin in chronic subdural hematoma. Neurol Med Chir. 2012;52(11):810–5.CrossRef Kitazono M, Yokota H, Satoh H, Onda H, Matsumoto G, Fuse A, Akira T. Measurement of inflammatory cytokines and thrombomodulin in chronic subdural hematoma. Neurol Med Chir. 2012;52(11):810–5.CrossRef
35.
go back to reference Balser D, Farooq S, Mehmood T, Quigley MR. Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. J Neurosurg. 2015;123:1209–15.PubMedPubMedCentralCrossRef Balser D, Farooq S, Mehmood T, Quigley MR. Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. J Neurosurg. 2015;123:1209–15.PubMedPubMedCentralCrossRef
36.
go back to reference Miranda LB, Braxton E, Hobbs J, et al. Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg. 2011;114:72–6.PubMedCrossRef Miranda LB, Braxton E, Hobbs J, et al. Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg. 2011;114:72–6.PubMedCrossRef
37.
go back to reference Ramachandran R, Hegde T. Chronic subdural hematomas–causes of morbidity and mortality. Surg Neurol. 2007;67:367–72.PubMedCrossRef Ramachandran R, Hegde T. Chronic subdural hematomas–causes of morbidity and mortality. Surg Neurol. 2007;67:367–72.PubMedCrossRef
38.
go back to reference Waqas M, Vakhari K, Weimer PV, Hashmi E, Davies JM, Siddiqui AH. Safety and effectiveness of embolization for chronic subdural hematoma: systematic review and case series. World Neurosurg. 2019;126:228–36.PubMedCrossRef Waqas M, Vakhari K, Weimer PV, Hashmi E, Davies JM, Siddiqui AH. Safety and effectiveness of embolization for chronic subdural hematoma: systematic review and case series. World Neurosurg. 2019;126:228–36.PubMedCrossRef
39.
go back to reference Wakai S, Hashimoto K, Watanabe N, Inoh S, Ochiai C, Nagai M. Efficacy of closed system drainage in treating chronic subdural hematoma: a prospective comparative study. Neurosurgery. 1990;26:771–3.PubMedCrossRef Wakai S, Hashimoto K, Watanabe N, Inoh S, Ochiai C, Nagai M. Efficacy of closed system drainage in treating chronic subdural hematoma: a prospective comparative study. Neurosurgery. 1990;26:771–3.PubMedCrossRef
40.
go back to reference Hellwig D, Kuhn TJ, Bauer BL, List-Hellwig E. Endoscopic treatment of septated chronic subdural hematoma. Surg Neurol. 1996;45:272–7.PubMedCrossRef Hellwig D, Kuhn TJ, Bauer BL, List-Hellwig E. Endoscopic treatment of septated chronic subdural hematoma. Surg Neurol. 1996;45:272–7.PubMedCrossRef
41.
go back to reference Smely C, Madlinger A, Scheremet R. Chronic subdural hematoma—a comparison of two different treatment modalities. Acta Neurochir. 1997;139:818–25.PubMedCrossRef Smely C, Madlinger A, Scheremet R. Chronic subdural hematoma—a comparison of two different treatment modalities. Acta Neurochir. 1997;139:818–25.PubMedCrossRef
42.
go back to reference Yoshimoto Y, Kwak S. Frontal small craniostomy and irrigation for treatment of chronic subdural haematoma. Br J Neurosurg. 1997;11:150–1.PubMedCrossRef Yoshimoto Y, Kwak S. Frontal small craniostomy and irrigation for treatment of chronic subdural haematoma. Br J Neurosurg. 1997;11:150–1.PubMedCrossRef
43.
44.
go back to reference Xu CS, Lu M, Liu LY, Yao MY, Cheng GL, Tian XY, Xiao F, Wan Q, Chen F. Chronic subdural hematoma management: clarifying the definitions of outcome measures to better understand treatment efficacy—a systematic review and metaanalysis. Eur Rev Med Pharmacol Sci. 2017;21:809–18.PubMed Xu CS, Lu M, Liu LY, Yao MY, Cheng GL, Tian XY, Xiao F, Wan Q, Chen F. Chronic subdural hematoma management: clarifying the definitions of outcome measures to better understand treatment efficacy—a systematic review and metaanalysis. Eur Rev Med Pharmacol Sci. 2017;21:809–18.PubMed
45.
go back to reference Gernsback J, Kolcun JP, Jagid J. To drain or two drains: recurrences in chronic subdural hematomas. World Neurosurg. 2016;95:447–50.PubMedCrossRef Gernsback J, Kolcun JP, Jagid J. To drain or two drains: recurrences in chronic subdural hematomas. World Neurosurg. 2016;95:447–50.PubMedCrossRef
46.
go back to reference Ban SP, Hwang G, Byoun HS, et al. Middle meningeal artery embolization for chronic subdural hematoma. Radiology. 2018;286:992–9.PubMedCrossRef Ban SP, Hwang G, Byoun HS, et al. Middle meningeal artery embolization for chronic subdural hematoma. Radiology. 2018;286:992–9.PubMedCrossRef
Metadata
Title
Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome
Authors
Olufemi Emmanuel Idowu
Stevens Olaide Oyeleke
Julius Mautin Vitowanu
Publication date
01-04-2022
Publisher
Springer Berlin Heidelberg
Keyword
Biomarkers
Published in
European Journal of Trauma and Emergency Surgery / Issue 2/2022
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-021-01665-5

Other articles of this Issue 2/2022

European Journal of Trauma and Emergency Surgery 2/2022 Go to the issue